PRKCG and colonic neoplasm: Furthermore, short-term treatment with PKCγ C1B domain peptides decreases anchorage-independent growth in the colon cancer cell line COLO205, while increasing expression of other PKC isozymes and p53 (Kawabata et al., 2012).